[Special Stock] Quantamatrix Demonstrates Leading Technology in Global Clinical Microbiology Testing Market

QuantaMatrix is showing strong performance. Kwon Seong-hoon, CEO of QuantaMatrix, stated, "The ‘uRAST’ technology published in the journal Nature is an all-in-one diagnostic technology that eliminates the blood culture process," and added, "Through this technology, QuantaMatrix is expected to lead the global clinical microbiology testing market, which integrates the approximately $5.6 billion antimicrobial susceptibility testing market and the approximately $4.3 billion blood culture market, totaling about $14.7 billion worldwide."

As of 1:21 PM on the 25th, QuantaMatrix is trading at 6,660 KRW, up 29.82% from the previous day.

QuantaMatrix, an innovative clinical microbiology diagnostics company, announced that the core technology of ‘uRAST (Ultra-Rapid Antimicrobial Susceptibility Testing)’, an all-in-one rapid antimicrobial susceptibility integrated testing solution jointly developed with Seoul National University Hospital and Seoul National University College of Engineering, has been published in the prestigious journal Nature.

In ‘uRAST’, synthetic nanoparticles with the ability to bind to microorganisms selectively isolate bacteria from blood to obtain pure bacterial samples, providing rapid test results. The test accuracy was 94.9%, showing high concordance with existing testing methods. It solved the technical challenge previously considered impossible, which is detecting a small number of bacteria (1/10^9 blood cells) in the early stages of blood infection. Commercializing uRAST technology is expected to offer faster and more accurate diagnostic and treatment opportunities for medical staff and patients.

According to the British medical journal The Lancet, 1.27 million people worldwide died from antibiotic resistance in 2019. It is reported that by 2050, the number will exceed 10 million, 1.2 times more than the 8.2 million deaths caused by cancer. The World Health Organization (WHO) has warned that the antibiotic resistance issue could cause the greatest health crisis at the level of the COVID-19 pandemic.